NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Collaborating Centre for Mental Health (UK). Drug Misuse: Opioid Detoxification. Leicester (UK): British Psychological Society; 2008. (NICE Clinical Guidelines, No. 52.)

Cover of Drug Misuse

Drug Misuse: Opioid Detoxification.

Show details

APPENDIX 2DECLARATIONS OF INTEREST BY GUIDELINE DEVELOPMENT GROUP MEMBERS

With a range of practical experience relevant to drug misuse in the GDG, members were appointed because of their understanding and expertise in healthcare for people who misuse drugs and support for their families and carers, including: scientific issues; health research; the delivery and receipt of healthcare, along with the work of the healthcare industry; and the role of professional organisations and organisations for people who misuse drugs and their families and carers.

To minimise and manage any potential conflicts of interest, and to avoid any public concern that commercial or other financial interests have affected the work of the GDG and influenced guidance, members of the GDG must declare as a matter of public record any interests held by themselves or their families that fall under specified categories (see below). These categories include any relationships they have with the healthcare industries, professional organisations and organisations for people who misuse drugs and their families and carers.

Individuals invited to join the GDG were asked to declare their interests before being appointed. To allow the management of any potential conflicts of interest that might arise during the development of the guideline, GDG members were also asked to declare their interests at each GDG meeting throughout the guideline development process. The interests of all the members of the GDG are listed below, including interests declared prior to appointment and during the guideline development process.

CATEGORIES OF INTEREST

  • Paid employment
  • Personal interests related to drug misuse: payment in cash or kind and/or funding from the drug misuse-related healthcare industry, including consultancies, grants, fee-paid work and shareholdings or other beneficial interests.
  • Personal interests not specifically related to drug misuse: any other payment and/or funding from the healthcare industry, including consultancies, grants and shareholdings or other beneficial interests.
  • Non-personal interests: funding from the healthcare industry received by the GDG member’s organisation or department, but where the GDG member has not personally received payment, including fellowships and other support provided by the healthcare industry.
  • Personal non-monetary interests: these include, but are not limited to, clear opinions or public statements you have made about drug misuse, holding office in a professional organisation or advocacy group with a direct interest in drug misuse, other reputational risks relevant to drug misuse.
  • Personal family interests: payments in cash or kind that were received by a member of your family.
  • Other interests relating to drug misuse: funding from governmental or nongovernmental organisations, charities, and so on, and/or ownership in a company that provides therapy or treatments likely to be covered in the guideline.
Declarations of interest
Dr Clare Gerada – Chair, Guideline Development Group
EmploymentGeneral Practitioner, Lambeth Primary Care, Trust, London Practice; Primary Care Lead for Drug Misuse and Chair at the Royal College of General Practitioners
Personal interests related to drug misuseMember of Suboxone Expert Group at Schering-Plough (attended two meetings, received payment of £1000); member of Specialist Opioid Advisory Group at Napp Pharmaceuticals (reimbursed expenses for attending only)
Personal interests not specifically related to drug misuseMember of Hepatitis C Expert Group at Roche (attended two meetings, received payment of £800)
Non-personal interestsRoyal College of General Practitioners received funding from Schering-Plough for educational material
Personal non-monetary interestsSpoken publicly about heroin treatment: against heroin treatment until methadone treatment is adequately resourced
Personal family interestsNone
Other interests related to drug misuseConsultancy fees from Royal College of General Practitioners for training GPs in substance misuse; Advisor to Royal College of General Practitioners on all matters relating to substance misuse; Given evidence to General Medical Council on GPs’ level of performance.
Attended number of meetings run by Schering-Plough looking at feasibility of Suboxone as a treatment in the UK
Attended Roche-funded hepatitis C meeting
Mrs Pauline Bissett
EmploymentRetired (previously Chief Executive, Broadway Lodge until December 2006)
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsNone
Personal non-monetary interestsNone
Personal family interestsNone
Other interests related to drug misuseNone
Mr Neil Connelly
EmploymentVoluntary Support Worker, Littledale Hall Therapeutic Community, Lancaster
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsNone
Personal non-monetary interestsNone
Personal family interestsNone
Other interests related to drug misuseNone
Dr Paul Davis
EmploymentConsultant Lead Clinical Psychologist and Head of Psychology for Substance Misuse Services, Camden and Islington Mental Health and Social Care Trust
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsNone
Personal non-monetary interestsEmployed 1 day per week by National Treatment Agency for Substance Misuse as Clinical Psychology Advisor (September 2006–2008)
Personal family interestsNone
Other interests related to drug misuseCurrent grant funded projects: A study of the feasibility of routine screening and ‘Stepped Care’ psychological interventions with hazardous and problem drinkers in three inner London General Hospitals (London Health Action Zone 2003–2005, £47,000)
Ms Vivienne Evans
EmploymentChief Executive, Adfam; Non-executive director of Charnwood and North West Leicestershire Primary Care Trust
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interests£6000 sponsorship from Schering-Plough to cover expenses of hosting Adfam’s 21st birthday celebration, October 2005
Personal non-monetary interestsNone
Personal family interestsNone
Other interests related to drug misuseNone
Dr Emily Finch
EmploymentAddiction Psychiatrist, South London and Maudsley NHS Foundation Trust; Clinical Team Lead, National Treatment Agency for Substance Misuse
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsNone
Personal non-monetary interestsTrustee of Phoenix House
Personal family interestsNone
Other interests related to drug misuseTrustee of Phoenix House; Seconded two days per week to the NTA (October 2004 – January 2007)
Professor Robert Forrest
EmploymentConsultant in Clinical Chemistry and Toxicology, Sheffield Teaching Hospitals NHS Foundation Trust
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsNone
Personal non-monetary interestsPresident of Forensic Science Society; Assistant Deputy Coroner, South Yorkshire (West); Programme Chair, Jurisprudence Section, American Academy of Forensic Sciences; expert witness in many cases where the issues are relevant to drug misuse; member of the editorial board for Science and Justice; member of Secretary of State’s Medical Advisory Committee on Alcohol, Driving and Drugs
Personal family interestsNone
Other interests related to drug misuseConsultancy work (remitted to employer) for Forensic Alliance Ltd, now part of the Laboratory of the Government Chemist (LGC)
Dr Eilish Gilvarry
EmploymentClinical Director, Newcastle Drug and Alcohol Unit, Newcastle upon Tyne
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsNone
Personal non-monetary interestsNone
Personal family interestsNone
Other interests related to drug misuseNone
Mr David Harding-Price
EmploymentTeam Coordinator, Community Mental Health Team, Skegness, Lincolnshire
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsEli Lilly 2005 funded mental health educational event at RCN congress; Janssen-Cilag 2005 sponsored European mental health educational conference
Personal non-monetary interestsNone
Personal family interestsNone
Other interests related to drug misuseNone
Mr Paul Hawkins
EmploymentNone
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsMember of executive board for Cumbria Alcohol and Drugs Advisory Service
Personal non-monetary interestsNone
Personal family interestsNone
Other interests related to drug misuseNone
Dr Anne Lingford-Hughes
EmploymentReader in Biological Psychiatry and Addiction, Academic Unit of Psychiatry, University of Bristol; Addiction Psychiatrist, Avon and Wiltshire Mental Health Trust
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseMember of core faculty and steering group for Bristol-Myers Squibb, 2004, £2000; Honorarium from Janssen-Cilag for presentation, 2005; Honorarium from Bristol-Myers Squibb for plenary lecture, £499.23, 2007; Consultancy fee from Sanofi-Aventis, £1000, 2006; Health hearing systems for Johnson and Johnson Pharmaceutical services, 2003, £1451.72; Unrestricted grants for research; Merck, £50,000, 2004; Wyeth, £70,000, 2000
Non-personal interestsPsychopharmacology Unit, University of Bristol: Fellowship – Lundbeck; Within last 5 years department received various unrestricted grants from GSK, Astra-Zeneca, MSD, Wyeth, Novartis, Bristol-Myers Squibb
Personal non-monetary interestsHon General Secretary of British Association for Psychopharmacology (BAP) – responsible for educational activities including opioid detoxification and coordinated BAP Consensus Guidelines, 2004, covering management of opioid detoxification.
Personal family interestsNone
Other interests related to drug misuseNone
Ms Jan Palmer
EmploymentNurse Consultant, Clinical Substance Misuse Lead, Offender Health
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsNone
Personal non-monetary interestsNone
Personal family interestsNone
Other interests related to drug misuseNone
Mrs Kay Roberts
EmploymentPharmacist; Chairman, PharMAG
Personal interests related to drug misuseWells Healthcare (for Schering-Plough) consultancy fees for training events; advisory board for Scotland: Suboxone, £800 in 2002, £360 in 2003; member of advisory board for Frontier Medical
Personal interests not specifically related to drug misuseNone
Non-personal interestsPharMAG receives in sponsorship and printing costs:
Britannia Pharmaceuticals £250 per annum
Reckitt Benckiser Ltd £1500, 2006; Rosemont Pharmaceuticals Ltd £1350, 2003–2005
Frontier Medical Ltd £250 per annum
Cardinal Healthcare (Martindale Pharmaceuticals) £2000, 2006
Personal non-monetary interestsRoyal College of General Practitioners, Lead Pharmacist (England) on Management of Substance Misuse in Primary Care; Royal College of General Practitioners (Scotland) tutor for Certificate in Management of Substance Misuse in Primary Care; Advisor to the Royal Pharmaceuticals Society of Great Britain on substance misuse; consultancy work for National Treatment Agency for Substance Misuse; member of the advisory council on misuse of drugs; member of UK Harm Reduction Alliance; member of Glasgow Children’s Hearings Panel; member of International Harm Reduction Association; member of Scottish Medico-legal Society
Personal family interestsNone
Other interests related to drug misuseNone

NCCMH STAFF

Mr Stephen Pilling – Facilitator, Guideline Development Group
EmploymentJoint Director, NCCMH; Director, Centre for Outcomes Research and Effectiveness, University College London; Consultant Clinical Psychologist and Deputy Head of Psychology Services, Camden and Islington Mental Health and Social Care Trust
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseLecture for UK Psychiatric Pharmacy Group, October 2006, £300 including expenses; Lecture at Andrew Simms Centre, Leeds, December 2006, £300 including expenses
Non-personal interestsGrants for production of clinical guidelines and evidence-related practice: British Psychological Society Clinical Effectiveness Programme with Professor P. Fonagy and Professor S. Michie supporting production of NICE guidelines and related policy implementation work (£5.4 million, 2001–2010)
Health service research grants: NHS Service Development and Organisation Research and Development Programme developing evidence-based and acceptable stepped-care systems in mental healthcare, an operational research project with Professor D. Richards, Professor S. Gallivan, Dr S. Gilbody, Professor K. Lovell, Dr J. Cape, Dr P. Bower and Ms J. Leibowitz (£299,642, 2006–2009); NHS Service Development and Organisation Research and Development Programme – The 100 Ward Study: a National Survey of Psychiatric Inpatient Unit Morale with Dr S. Johnson, Professor P. Bebbington, Professor M. King, Professor S. Woods, Professor N. Wellman, Dr D. Osborn and Dr R. Arraya (£296,999, 2006–2009)
Personal non-monetary interestsNone
Personal family interestsNone
Other interests related to drug misuseNone
Ms Sarah Hopkins
EmploymentProject Manager, NCCMH
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsNone
Personal non-monetary interestsNone
Personal family interestsNone
Other interests related to drug misuseNone
Ms Rebecca King
EmploymentProject Manager, NCCMH (2005–2006)
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsNone
Personal non-monetary interestsNone
Personal family interestsNone
Other interests related to drug misuseNone
Mr Ryan Li
EmploymentResearch Assistant, NCCMH
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsNone
Personal non-monetary interestsNone
Personal family interestsNone
Other interests related to drug misuseNone
Dr Nicholas Meader
EmploymentSystematic Reviewer, NCCMH
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsNone
Personal non-monetary interestsNone
Personal family interestsNone
Other interests related to drug misuseNone
Ms Poonam Sood
EmploymentResearch Assistant, NCCMH
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsNone
Personal non-monetary interestsNone
Personal family interestsNone
Other interests related to drug misuseNone
Ms Sarah Stockton
EmploymentInformation Scientist, NCCMH
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsNone
Personal non-monetary interestsNone
Personal family interestsNone
Other interests related to drug misuseNone
Dr Clare Taylor
EmploymentEditor, NCCMH
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsNone
Personal non-monetary interestsNone
Personal family interestsNone
Other interests related to drug misuseNone
Mr Loukas Xaplanteris
EmploymentHealth Economist, NCCMH
Personal interests related to drug misuseNone
Personal interests not specifically related to drug misuseNone
Non-personal interestsNone
Personal non-monetary interestsNone
Personal family interestsNone
Other interests related to drug misuseNone
Copyright © 2008, The British Psychological Society & The Royal College of Psychiatrists.

All rights reserved. No part of this book may be reprinted or reproduced or utilised in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording, or in any information storage or retrieval system, without permission in writing from the publishers. Enquiries in this regard should be directed to the British Psychological Society.

Bookshelf ID: NBK50640
PubReader format: click here to try

Views

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...